News

The European Commission (EC), Heads of Medicine Agencies (HMA), and European Medicines Agency (EMA) have released the 2022–2026 workplan for the programme Accelerating Clinical Trials in the EU (ACT EU). Building on the Clinical Trials Regulation (CTR) and Clinical Trials...

Dupixent, the immunology favourite developed by Sanofi and Regeneron Pharmaceuticals, is still on the rise. It has received back-to-back approvals this year for the treatment of eosinophilic esophagitis and paediatric eczema, and now the IL-4/IL-13 inhibitor has achieved a...

A group of Food and Drug Administration advisers has recently come out in favour of a carefully monitored ALS drug, increasing the likelihood that the agency will approve it in the coming weeks. The expert group voted 7-2 in favour...

Revance Therapeutics may soon run into an identity problem with a product that is so eagerly awaited that some people mistakenly call it by the name of the firm. Daxxify, Revance's long-awaited Botox rival, has officially received FDA approval,...

After unimpressive evidence on tumour progression, many Gilead Sciences investors have stopped believing in Trodelvy in HR-positive, HER2-negative breast cancer. But now that the antibody-drug combination has unexpectedly returned, blockbuster dreams have been rekindled thanks to a life extension...

If you are a total foodie and you’re looking for some inspiration, you’ve come to the right place. Food trends made for the Gram may come and go, but unique food and drink items with a special story behind...

Pharmaceuticals are a vital part of the healthcare industry. They help improve the quality of drugs and services they provide, as well as discover new drugs to cure deadly and complicated diseases. That said, it's crucial to streamline their...